| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3036 | |||||||||||||||||||||||
| Submitter : | Mrs. Annette Name | Date & Time: | 12/12/2006 09:12:08 | |||||||||||||||||||||
| Organization : | Mrs. Annette Name | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am asking you to issue guidelines to pharmaceutical companies that when manufacturing vaccines, they restrict their use of stem cells to those established from sources other than fetal tissue obtained from aborted babies. It makes sense to use non-objectionable cell lines in all vaccine production so everyone can benefit from them without compromising their moral beliefs. This is especially true since there is an abundance of ethical sources! Thank you. | ||||||||||||||||||||||||